1,007
Participants
Start Date
February 28, 2003
Primary Completion Date
August 8, 2006
Study Completion Date
August 31, 2008
MRI
Breast contralateral to the breast diagnosed with cancer was scanned prior to initiation of chemotherapy and within 90 days of a negative mammogram of the study breast. A recent (within 90 days) negative or benign mammogram (defined by final BI RADS category 1 or 2) and negative or benign clinical breast exam of the study breast were required for entry into the study.
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
Walter Reed Army Medical Center, Washington D.C.
Cancer Center at the University of Virginia, Charlottesville
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
Mayo Clinic, Jacksonville
Boca Raton Community Hospital, Boca Raton
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Memorial Medical Center, Springfield
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock
Porter Adventist Hospital, Denver
UCSF Comprehensive Cancer Center, San Francisco
Seattle Cancer Care Alliance, Seattle
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
Hartford Hospital, Hartford
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Charles M. Barrett Cancer Center at University Hospital, Cincinnati
Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia
Allegheny General Hospital, Pittsburgh
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas
University of Toronto, Toronto
Universitaetsklinikum Bonn, Bonn
National Cancer Institute (NCI)
NIH
American College of Radiology Imaging Network
NETWORK